Equity Components [Axis] Common Stock [Member] Preferred Stock [Member] Class of Stock [Axis] Series F Preferred Stock [Member] Subscription Receivable Preferred Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Option Exchange Agreement [Member] Sale of Stock [Axis] Private Placement [Member] Legal Entity [Axis] Sanovas Ophthalmology LLC [Member] Antidilutive Securities [Axis] Stock Options [Member] Warrant [Member] Diopsys, Inc. [Member] Related Party [Axis] Original Employment Agreement [Member] Mr. Gerrans [Member] Amended and Restated Employment Agreement [Member] Halo Management LLC [Member] Plan Name [Axis] 2017 Equity Incentive Plan [Member] Statistical Measurement [Axis] Maximum [Member] Award Type [Axis] Title of Individual [Axis] CEO and Consultant [Member] Error Correction, Type [Axis] Mathematical Error [Member] Sanovas Offering [Member] Tax Period [Axis] No Expiration Date [Member] Expire in 2034 [Member] Expire in 2030 [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Consulting Firm [Member] Sanovas Ophthalmology LLC [Member] Exercise Price Range [Axis] Exercise Price One [Member] Exercise Price Two [Member] Directors [Member] Halo Management Group LLC [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current Assets Cash Due from Sanovas Deferred Offering Costs Total Current Assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ DEFICIT Current Liabilities Shareholder’s Loans Accounts Payable Due to Sanovas Accrued Interest Total Liabilities Stockholders’ Deficit: Preferred stock, Value Common stock, Value Additional paid in capital Preferred stock subscription receivable Accumulated deficit Total stockholders’ deficit TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue Costs and expenses Administrative Research and Development Stock-based compensation Total Operating Expenses (Loss) from operations Interest expense Net Loss Net Loss per share - basic and diluted Weighted average number of common shares outstanding during the period- basic and diluted Statement [Table] Statement [Line Items] Beginning balance, value Beginning balance, shares Stock based compensation Exercise of stock options Exercise of stock options, shares Exercise of warrants Exercise of warrants, shares Capital contribution by Sanovas (Note C) Retirement of due to Sanovas through the issuance of shares of common stock to Sanovas Ophthalmology LLC Retirement of due to Sanovas through the issuance of shares of common stock to Sanovas Ophthalmology LLC, shares Stock purchased by investors Stock purchased by investors, shares Deemed dividend Costs of stock sales Net loss Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Cash Flows From Operating Activities Stock based compensation expense Costs and expenses paid on behalf of Company by Sanovas, net Changes in operating assets and liabilities: Increase in current assets Increase in accounts payable Increase in accrued interest Total Adjustments Net cash used in operating activities Cash Flows From Financing Activities Change in stockholders refund payable, net Proceeds from common stock sold, net of costs Proceeds from shareholder loans Proceeds from exercise of warrants Proceeds from exercise of options Net cash provided by financing activities Net increase (decrease) in cash Cash at beginning of period Cash at end of period Supplemental information: Retirement of due to Sanovas to capital through the issuance of common stock to Sanovas Ophthalmology LLC (Note C) Capital contribution by Sanovas Accounting Policies [Abstract] HISTORY, BUSINESS PURPOSE, LIQUIDITY AND GOING CONCERN SIGNIFICANT ACCOUNTING POLICIES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Equity [Abstract] COMMON AND PREFERRED STOCK Stock Plan STOCK PLAN Warrants WARRANTS Income Tax Disclosure [Abstract] INCOME TAXES Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation Cash Equivalents Deferred Offering Costs Use of Estimates Income Taxes Income (Loss) Per Common Share Stock-based compensation Research and Development costs Recent Accounting Pronouncements SCHEDULE OF RELATED PARTY TRANSACTIONS SCHEDULE OF STOCK OPTION ACTIVITY SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE SCHEDULE OF STOCK OPTIONS FAIR VALUE ASSUMPTIONS SCHEDULE OF WARRANTS FAIR VALUE ASSUMPTIONS SCHEDULE OF WARRANTS ACTIVITY SCHEDULE OF WARRANTS OUTSTANDING Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Options to purchase shares, percentage Proceeds from issuance of private offering Capital contribution Value of shares issuance to offset due amounts Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Unrecognized tax benefits Accrued penalties and interest Anti-dilutive securities excluded from computation of earning per shares Balance due from Sanovas - beginning of period Costs paid by Sanovas on the Company's behalf Costs of Sanovas allocated to the Company Repayment of costs charged by Sanovas to the Company Subtotal Capital Contribution by Sanovas Retirement of due to Sanovas through the issuance of 390,358 and 358,126 shares of common stock to Sanovas Ophthalmology, respectively Balance due to Sanovas - ending of period Balance due from Sanovas - beginning of period Number of issuance of shares due to retirement Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Related party cost Value of shares issuance to offset due amounts Schedule of Stock by Class [Table] Class of Stock [Line Items] Number of restricted shares issued Percentage of shares issued Number of shares issued during period Shares issued price per share Sale of stock, shares issued Offering costs Due to related parties Preferred stock, voting right Preferred stock, dividend Preferred stock, conversion price Proceeds from issuance of preferred stock Schedule Of Stock Option Activity Stock Options, Outstanding, Beginning Balance Weighted Average Exercise Price, Beginning Balance Stock Options, Granted Weighted Average Exercise Price, Granted Stock Options, Canceled Weighted Average Exercise Price, Canceled Stock Options, Exercised Weighted Average Exercise Price, Exercised Stock Options, Outstanding, Ending Balance Weighted Average Exercise Price, Ending Balance Schedule Of Stock Options Outstanding And Exercisable Exercise Price Number of Options Outstanding Weighted Average Remaining Contractual Life Number of Options Exercisable Risk-free interest rates Expected life in years Expected volatility Expected dividend yield Fair value common stock Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Common stock shares reserved for future issuance Number of stock options to purchase common stock Exercise price Aggregate fair value of stock options Unrecognized compensation expense Weighted-average period for recognition Fair value of share price Options, vesting period Schedule Of Warrants Activity Warrants, Outstanding, Beginning Balance Weighted Average Exercise Price, Beginning Balance Warrants, Granted Weighted Average Exercise Price, Granted Warrants, Canceled Weighted Average Exercise Price, Canceled Warrants, Exercised Weighted Average Exercise Price, Exercised Warrants, Outstanding, Ending Balance Weighted Average Exercise Price, Ending Balance Share-based Payment Arrangement, Option, Exercise Price Range [Table] Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] Exercise Price Number Outstanding Weighted Average Remaining Contractual Life Number Exercisable Net amount of shares issued Issuance of warrants to purchase common stock Warrant exercise price Decrease in awards of common stock Warrants estimated fair value Number of shares issued Offering value of common stock designated Amount contributed to captial Warrants term Dividend yield, percentage Unrecognized compensation expenses Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Operating loss carryforwards, limitation on use Operating loss carryforwards Deferred tax assets, net Changes in valuation allowance Subsequent Event [Table] Subsequent Event [Line Items] Sale of stock price per share Number of shares rescinded Option Exchange Agreement [Member]. Sanovas Ophthalmology LLC [Member]. 2017 Equity Incentive Plan [Member]. Stock Options [Member]. Diopsys, Inc. [Member] Consulting Firm [Member] Original Employment Agreement [Member]. Mr. Gerrans [Member] Amended and Restated Employment Agreement [Member]. Sanovas Ophthalmology LLC [Member] Halo Management LLC [Member] No Expiration Date [Member] Expire in 2034 [Member] Expire in 2030 [Member] Capital contribution. Shares issued for repayment of debt value. Shares issued for repayment of debt shares. Change in stockholders refund payable. Deferred Offering Costs [Policy Text Block] Due to related parties. Due to related parties gross. Stock issued during period shares retirement. Stock issued during period value retirement. Stock Plan Disclosure [Text Block]. Fair value of share price. Warrants Disclosure [Text Block] Share Based Compensation Arrangement By Share Based Payment Award Non-Options Outstanding Weighted Average Exercise Price. Share Based Compensation Arrangement By Share Based Payment Award Non-Options Outstanding Weighted Average Exercise Price Granted. Share Based Compensation Arrangement By Share Based Payment Award Non-Options Outstanding Weighted Average Exercise Price Cancelled. Share Based Compensation Arrangement By Share Based Payment Award Non-Options Outstanding Weighted Average Exercise Price Exercised. Number of shares rescind during period. Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Exercisable Number. Schedule of Warrant Outstanding [TableText Block] Adjustments to Additional paid in capital capital contribution. CEO and Consultant [Member] Mathematical Error [Member] Sanovas Offering [Member] Offering value of stock designated. Deemed dividend. Directors [Member] Halo Management Group LLC [Member] Subscription Receivable Preferred Stock [Member] Sanovas Ophthalmology LLC [Member] [Default Label] Assets, Current Assets Liabilities Preferred Stock, Shares Subscribed but Unissued, Subscriptions Receivable Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Shares, Outstanding Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Increase (Decrease) in Other Current Assets Net Cash Provided by (Used in) Operating Activities ChangeInStockholdersRefundPayable Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect DeferredOfferingCostsPolicyTextBlock Compensation Related Costs, Policy [Policy Text Block] DueToRelatedParties Debt Conversion, Converted Instrument, Shares Issued ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceGranted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceCancelled Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExercised Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms